Ergoteles LLC Iqvia Holdings Inc. Transaction History

Ergoteles LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$183.66 - $224.77 $4.85 Million - $5.94 Million	-26,414 Reduced 95.35%	1,289 $289,000
Q1 2023 May 10, 2023	BUY	$188.0 - $240.65 $5.21 Million - $6.67 Million	27,703 New	27,703 $5.51 Million
Q3 2022 Nov 14, 2022	BUY	$181.14 - $248.26 $4.27 Million - $5.86 Million	23,593 Added 970.91%	26,023 $4.71 Million
Q2 2022 Aug 12, 2022	SELL	$196.45 - $252.29 $444,173 - $570,427	-2,261 Reduced 48.2%	2,430 $527,000
Q1 2022 May 13, 2022	BUY	$210.56 - $273.58 $769,386 - $999,661	3,654 Added 352.36%	4,691 $1.09 Million
Q4 2021 Feb 14, 2022	BUY	$238.37 - $282.61 $247,189 - $293,066	1,037 New	1,037 $293,000
Q2 2021 Aug 12, 2021	SELL	$198.06 - $246.77 $2.3 Million - $2.86 Million	-11,590 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$173.0 - $194.59 $751,339 - $845,104	4,343 Added 59.93%	11,590 $2.24 Million
Q4 2020 Feb 11, 2021	BUY	$153.99 - $180.39 $1.12 Million - $1.31 Million	7,247 New	7,247 $1.3 Million

1,137

142M

828K

951K

Ticker IQV
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 185,740,000
Market Cap $35.8B
Description
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The ...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.